You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD30-expression

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma Trial in Berne (Brentuximab Vedotin, BeEAM Regimen)

Recruiting
  • Lymphoma
  • Brentuximab Vedotin
  • BeEAM Regimen
  • Berne, Switzerland
    Department for Medical Oncology University Hospital/Inselspital
Feb 4, 2022

Cancer, Relapsed/Refractory Large B-cell Lymphoma (LBCL) Trial (Fludarabine (30 mg/m^2), Cyclophosphamide (500 mg/m^2), CRG-022

Not yet recruiting
  • Cancer
  • Relapsed/Refractory Large B-cell Lymphoma (LBCL)
  • Fludarabine (30 mg/m^2)
  • +2 more
  • (no location specified)
Jul 25, 2023

Lymphatic Diseases Trial in Italy (Brentuximab Vedotin, Bendamustine)

Terminated
  • Lymphatic Diseases
  • Bologna, BO, Italy
  • +4 more
May 26, 2021

CD133 Expression in Mammary Invasive Ductal Carcinoma

Recruiting
  • Breast Cancer
    • Sohag, Egypt
    • +1 more
    May 5, 2021

    Classic Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in United States (drug, other,

    Active, not recruiting
    • Classic Hodgkin Lymphoma
    • +2 more
    • Brentuximab Vedotin
    • +2 more
    • Duarte, California
    • +5 more
    Mar 17, 2022

    Solid Tumor Trial in Suzhou (68Ga-NODAGA-SNA006)

    Recruiting
    • Solid Tumor
    • 68Ga-NODAGA-SNA006
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Jul 8, 2022

    AIDS-Related Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in France, United

    Active, not recruiting
    • AIDS-Related Hodgkin Lymphoma
    • +11 more
    • Brentuximab Vedotin
    • +4 more
    • La Jolla, California
    • +27 more
    Jul 27, 2022

    Brentuximab Vedotin in Pediatric Hodgkin Lymphoma

    Not yet recruiting
    • Hodgkin Lymphoma
    • Brentuximab Vedotin
    • (no location specified)
    Jul 28, 2022

    Non Hodgkin's Lymphoma Trial in China (Chidamide, Fludarabine and cyclophosphamide, Anti-CD19 CAR-T cells)

    Recruiting
    • Non Hodgkin's Lymphoma
    • Beijing, Beijing, China
    • +12 more
    Jun 9, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +7 more
    • Blinatumomab
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 31, 2022

    Gold Nanoparticles in Salivary Gland Tumours

    Completed
    • Carcinoma Ex Pleomorphic Adenoma of Salivary Glands
    • Pleomorphic Adenoma of Salivary Glands
    • CD24-Gold Nanocomposite expression using Real-time quantitative polymerase chain reaction
    • non-conjugated CD24 expression using Real-time quantitative polymerase chain reaction
    • Giza, Egypt
      Faculty of Dentistry, October 6 University
    Aug 31, 2021

    Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma, Ann Arbor Stage II Primary Mediastinal (Thymic) Large

    Recruiting
    • Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma
    • +3 more
    • Brentuximab Vedotin
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 10, 2022

    Relapsed or Refractory CD30+ Malignancies When Re-treated With

    Completed
    • Hodgkin Disease
    • Lymphoma, T-Cell, Cutaneous
    • No Intervention
    • San Bartolome, Alicante, Spain
    • +29 more
    Jul 28, 2022

    Cancer, Malignant Tumor Trial in Chapel Hill (Bioelectrical impedance Analysis (BIA), D3-Creatine Dilution (D3Cr), 6-Minute Walk

    Not yet recruiting
    • Cancer
    • Malignant Neoplasm
    • Bioelectrical impedance Analysis (BIA)
    • +7 more
    • Chapel Hill, North Carolina
      UNC Lineberger Comprehensive Cancer Center
    Apr 10, 2023

    HIV Infection, HIV-associated Hodgkin Lymphoma, Stage III Adult Hodgkin Lymphoma Trial in France (brentuximab vedotin,

    Active, not recruiting
    • HIV Infection
    • +3 more
    • brentuximab vedotin
    • +3 more
    • Clamart, France
    • +5 more
    Aug 11, 2022

    Brentuximab Vedotin in Adults With CD30-positive Lymphoma

    Recruiting
    • Lymphoma
    • No Intervention
    • Hefei, Anhui, China
    • +25 more
    Jul 14, 2022

    Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Enteropathy-Associated T-Cell Lymphoma, Recurrent Follicular T-Cell

    Recruiting
    • Recurrent Angioimmunoblastic T-Cell Lymphoma
    • +13 more
    • Brentuximab Vedotin
    • Pembrolizumab
    • Chicago, Illinois
      Northwestern University
    Jun 15, 2022

    Breast Cancer Trial (Diagnostic microprobe (inPROBE) medical device)

    Recruiting
    • Breast Cancer
    • Diagnostic microprobe (inPROBE) medical device
    • Kraków, Poland
    • +1 more
    Nov 2, 2022

    DLBCL Trial in Rotterdam (R-DHAP, Brentuximab Vedotin)

    Recruiting
    • DLBCL
    • R-DHAP
    • Brentuximab Vedotin
    • Rotterdam, Netherlands
      NL-Rotterdam-ERASMUSMC
    Dec 9, 2020

    Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial (procedure, drug, biological, radiation, other)

    Not yet recruiting
    • Recurrent Classic Hodgkin Lymphoma
    • Refractory Classic Hodgkin Lymphoma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +13 more
    • (no location specified)
    Feb 2, 2023

    Expression of CD19 Complex in Lymphoproliferative Disorders

    Not yet recruiting
    • Lymphoproliferative Disorders
    • Flow cytometry
    • (no location specified)
    Feb 2, 2021

    Ann Arbor Stage IB Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in United

    Active, not recruiting
    Has Results
    • Ann Arbor Stage IB Hodgkin Lymphoma
    • +10 more
    • Brentuximab Vedotin
    • Nivolumab
    • Palo Alto, California
    • +8 more
    Jul 20, 2022

    Postoperative Infectious Complications in Colorectal Cancer

    Completed
    • Colorectal Cancer
      • Moscow, Russian Federation
        State Scientific Centre of Coloproctology
      Sep 21, 2021

      Metastatic Colorectal Cancer Trial in Worldwide (RO7122290, Cibisatamab, Obinutuzumab)

      Recruiting
      • Metastatic Colorectal Cancer
      • Toronto, Ontario, Canada
      • +15 more
      Jan 13, 2023

      B-cell Lymphoma Trial in Kunming (CTA30X UCAR-T injection)

      Recruiting
      • B-cell Lymphoma
      • CTA30X UCAR-T injection
      • Kunming, Yunnan, China
        No.212 Daguan Road, Xishan District
      Aug 15, 2021